Trinity Biotech (TRIB) Cash from Financing Activities (2021 - 2024)
Trinity Biotech recorded quarterly Cash from Financing Activities of $1.8 million in Q4 2024, up 202.21% quarter-over-quarter from -$1.8 million in Q4 2023, and up 202.21% year-over-year from $597270.0 in Q1 2024.
Trinity Biotech's Cash from Financing Activities history runs 4 years deep, the most recent figure standing at $1.8 million for Q4 2024.
- In Q4 2024, Cash from Financing Activities rose 202.21% year-over-year to $1.8 million; the TTM figure through Dec 2024 stood at -$4.2 million (up 49.64% YoY), while the FY2025 annual figure was $12.1 million, down 58.17% from the prior year.
- Cash from Financing Activities came in at $1.8 million for Q4 2024 at Trinity Biotech, up from -$1.8 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $1.8 million in Q4 2024 to a low of -$3.6 million in Q4 2021.
- A 4-year average of -$1.7 million and a median of -$2.1 million in 2022 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities fell 2.49% in 2023 and surged 202.21% in 2024, its largest moves.
- Trinity Biotech's Cash from Financing Activities stood at -$3.6 million in 2021, then jumped by 48.56% to -$1.8 million in 2022, then increased by 4.28% to -$1.8 million in 2023, then soared by 202.21% to $1.8 million in 2024.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $1.8 million, -$1.8 million, and -$2.4 million for Q4 2024, Q4 2023, and Q3 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.81 Mn |
| Dec 31, 2024 | 1.81 Mn |
| Dec 31, 2023 | -1.77 Mn |
| Dec 31, 2023 | -1.77 Mn |
| Sep 30, 2023 | -2.43 Mn |
| Sep 30, 2023 | -2.43 Mn |
| Dec 31, 2022 | -1.85 Mn |
| Dec 31, 2022 | -1.85 Mn |
| Sep 30, 2022 | -2.37 Mn |
| Sep 30, 2022 | -2.37 Mn |
| Dec 31, 2021 | -3.59 Mn |
| Dec 31, 2021 | -3.59 Mn |